Pandeia Therapeutics Limited CAMBRIDGE


Pandeia Therapeutics Limited is a private limited company registered at C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge CB22 3FH. Its total net worth is valued to be roughly 0 pounds, while the fixed assets the company owns come to 0 pounds. Incorporated on 2018-07-13, this 5-year-old company is run by 1 director.
Director Austin K., appointed on 22 December 2022.
The company is officially categorised as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110).
The last confirmation statement was sent on 2023-06-26 and the date for the next filing is 2024-07-10. Moreover, the annual accounts were filed on 31 August 2022 and the next filing should be sent on 31 May 2024.

Pandeia Therapeutics Limited Address / Contact

Office Address C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building
Office Address2 Babraham Research Campus, Babraham
Town Cambridge
Post code CB22 3FH
Country of origin United Kingdom

Company Information / Profile

Registration Number 11463856
Date of Incorporation Fri, 13th Jul 2018
Industry Research and experimental development on biotechnology
End of financial Year 31st August
Company age 6 years old
Account next due date Fri, 31st May 2024 (32 days left)
Account last made up date Wed, 31st Aug 2022
Next confirmation statement due date Wed, 10th Jul 2024 (2024-07-10)
Last confirmation statement dated Mon, 26th Jun 2023

Company staff

Austin K.

Position: Director

Appointed: 22 December 2022

The Cambridge Partnership Limited

Position: Corporate Secretary

Appointed: 09 August 2019

Francesco D.

Position: Director

Appointed: 19 September 2019

Resigned: 22 December 2022

David G.

Position: Director

Appointed: 19 September 2019

Resigned: 22 December 2022

John M.

Position: Director

Appointed: 05 March 2019

Resigned: 22 December 2022

Martin Q.

Position: Director

Appointed: 05 March 2019

Resigned: 19 September 2019

Timothy S.

Position: Director

Appointed: 13 July 2018

Resigned: 30 July 2019

People with significant control

The register of PSCs that own or have control over the company consists of 5 names. As we researched, there is Acadia Pharmaceuticals Inc. from San Diego, United States. The abovementioned PSC is categorised as "a company" and has 75,01-100% shares. The abovementioned PSC and has 75,01-100% shares. Another entity in the persons with significant control register is Medicxi Ventures i Lp that entered Jersey, Jersey as the official address. This PSC has a legal form of "a limited partnership", owns 75,01-100% shares. This PSC owns 75,01-100% shares. The third one is Timothy S., who also meets the Companies House requirements to be indexed as a PSC. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Acadia Pharmaceuticals Inc.

12830 El Camino Real, Ste. 400, San Diego, Ca 92130-2976, United States

Legal authority The General Corporation Law Of The State Of Delaware
Legal form Company
Notified on 22 December 2022
Nature of control: 75,01-100% shares

Medicxi Ventures I Lp

44 Esplanade, St Helier, Jersey, JE4 9WG, Jersey

Legal authority Limited Partnerships (Jersey) Law 1994
Legal form Limited Partnership
Country registered Jersey
Place registered Jersey
Registration number 2010
Notified on 20 September 2019
Ceased on 22 December 2022
Nature of control: 75,01-100% shares

Timothy S.

Notified on 13 July 2018
Ceased on 20 September 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Fraser M.

Notified on 5 March 2019
Ceased on 5 March 2019
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares

Martin Q.

Notified on 5 March 2019
Ceased on 5 March 2019
Nature of control: 25-50% voting rights
right to appoint and remove directors
25-50% shares

Annual reports financial information

Profit & Loss
Accounts Information Date 2019-12-312020-12-312021-12-312022-08-31
Balance Sheet
Cash Bank On Hand1 385 926364 3571 525 884796 269
Current Assets1 561 590877 4671 744 9071 076 392
Debtors175 664513 110219 023280 123
Other Debtors168 655511 623217 498278 598
Property Plant Equipment2 1821 7221 263957
Other
Accumulated Depreciation Impairment Property Plant Equipment1165761 0351 341
Average Number Employees During Period1333
Creditors157 043134 111116 338247 747
Increase From Depreciation Charge For Year Property Plant Equipment116460459306
Net Current Assets Liabilities1 404 547743 3561 628 569828 645
Other Creditors12 0395 6883 7096 301
Property Plant Equipment Gross Cost2 2982 2982 298 
Total Additions Including From Business Combinations Property Plant Equipment2 298   
Total Assets Less Current Liabilities1 406 729745 0781 629 832829 602
Trade Creditors Trade Payables145 004128 423112 629241 446
Trade Debtors Trade Receivables7 0091 4871 5251 525

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Current accounting period extended from 2023-08-31 to 2023-12-31
filed on: 6th, December 2023
Free Download (1 page)

Company search